BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8299233)

  • 1. Homozygosity for a missense mutation (G20R) associated with neonatal onset adenosine deaminase-deficient severe combined immunodeficiency (ADA-SCID).
    Yang DR; Huie ML; Hirschhorn R
    Clin Immunol Immunopathol; 1994 Feb; 70(2):171-5. PubMed ID: 8299233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
    Hirschhorn R; Yang DR; Insel RA; Ballow M
    Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel deletion and a new missense mutation (Glu 217 Lys) at the catalytic site in two adenosine deaminase alleles of a patient with neonatal onset adenosine deaminase- severe combined immunodeficiency.
    Hirschhorn R; Nicknam MN; Eng F; Yang DR; Borkowsky W
    J Immunol; 1992 Nov; 149(9):3107-12. PubMed ID: 1401934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An adenosine deaminase (ADA) allele contains two newly identified deleterious mutations (Y97C and L106V) that interact to abolish enzyme activity.
    Jiang C; Hong R; Horowitz SD; Kong X; Hirschhorn R
    Hum Mol Genet; 1997 Dec; 6(13):2271-8. PubMed ID: 9361033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five missense mutations at the adenosine deaminase locus (ADA) detected by altered restriction fragments and their frequency in ADA--patients with severe combined immunodeficiency (ADA-SCID).
    Hirschhorn R; Ellenbogen A; Tzall S
    Am J Med Genet; 1992 Jan; 42(2):201-7. PubMed ID: 1346349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry.
    Sanchez JJ; Monaghan G; Børsting C; Norbury G; Morling N; Gaspar HB
    Ann Hum Genet; 2007 May; 71(Pt 3):336-47. PubMed ID: 17181544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygosity for a newly identified missense mutation in a patient with very severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID).
    Hirschhorn R; Chakravarti V; Puck J; Douglas SD
    Am J Hum Genet; 1991 Oct; 49(4):878-85. PubMed ID: 1680289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.
    Arredondo-Vega FX; Santisteban I; Kelly S; Schlossman CM; Umetsu DT; Hershfield MS
    Am J Hum Genet; 1994 May; 54(5):820-30. PubMed ID: 8178821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA.
    Santisteban I; Arredondo-Vega FX; Kelly S; Loubser M; Meydan N; Roifman C; Howell PL; Bowen T; Weinberg KI; Schroeder ML
    Hum Mol Genet; 1995 Nov; 4(11):2081-7. PubMed ID: 8589684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delG, and E337del. Mutations in brief no. 142. Online.
    Arrendondo-Vega FX; Santisteban I; Notarangelo LD; El Dahr J; Buckley R; Roifman C; Conley ME; Hershfield MS
    Hum Mutat; 1998; 11(6):482. PubMed ID: 10200056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two newly identified mutations (Thr233Ile and Leu152Met) in partially adenosine deaminase-deficient (ADA-) individuals that result in differing biochemical and metabolic phenotypes.
    Hirschhorn R; Borkowsky W; Jiang CK; Yang DR; Jenkins T
    Hum Genet; 1997 Jul; 100(1):22-9. PubMed ID: 9225964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different chromosomal backgrounds and apparent intragenic crossover.
    Hirschhorn R; Yang DR; Israni A
    Ann Hum Genet; 1994 Jan; 58(1):1-9. PubMed ID: 8031011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homozygous 5 base-pair deletion in exon 10 of the adenosine deaminase (ADA) gene in a child with severe combined immunodeficiency and very low levels of ADA mRNA and protein.
    Gossage DL; Norby-Slycord CJ; Hershfield MS; Markert ML
    Hum Mol Genet; 1993 Sep; 2(9):1493-4. PubMed ID: 8242080
    [No Abstract]   [Full Text] [Related]  

  • 15. Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: Segregation of genotypes with specific ethnicities.
    Adams SP; Wilson M; Harb E; Fairbanks L; Xu-Bayford J; Brown L; Kearney L; Madkaikar M; Bobby Gaspar H
    Clin Immunol; 2015 Dec; 161(2):174-9. PubMed ID: 26255240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery.
    Hirschhorn R; Yang DR; Israni A; Huie ML; Ownby DR
    Am J Hum Genet; 1994 Jul; 55(1):59-68. PubMed ID: 8023852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.
    Santisteban I; Arredondo-Vega FX; Kelly S; Mary A; Fischer A; Hummell DS; Lawton A; Sorensen RU; Stiehm ER; Uribe L
    J Clin Invest; 1993 Nov; 92(5):2291-302. PubMed ID: 8227344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles.
    Arredondo-Vega FX; Santisteban I; Daniels S; Toutain S; Hershfield MS
    Am J Hum Genet; 1998 Oct; 63(4):1049-59. PubMed ID: 9758612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).
    Kühl JS; Schwarz K; Münch A; Schmugge M; Pekrun A; Meisel C; Wahn V; Ebell W; von Bernuth H
    Klin Padiatr; 2011 Mar; 223(2):85-9. PubMed ID: 21271505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of two new missense mutations (R156C and S291L) in two ADA- SCID patients unusual for response to therapy with partial exchange transfusions.
    Hirschhorn R
    Hum Mutat; 1992; 1(2):166-8. PubMed ID: 1284479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.